Sabuwar dandamalin farfaɗo don kawo sauyi akan jiyya mai ƙarfi

A KYAUTA Kyauta 1 | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

A2 Biotherapeutics, Inc., wani kamfani na kimiyyar halittu da ke mai da hankali kan maganin ciwace-ciwacen ciwace-ciwace, ya sanar a yau cewa an buga mahimman bayanan da suka shafi dandalin jiyya na Tmod ™ na mallakar su a cikin Magungunan Fassarar Kimiyya da Jarida don ImmunoTherapy of Cancer. An tsara maganin Tmod™ don masu ciwon daji waɗanda ciwace-ciwacen daji ke ɗauke da takamaiman gogewar kwayoyin halitta, kuma gwajin ƙwayoyin cuta yana ba da damar gano marasa lafiya da wuri waɗanda za su iya amfana da irin wannan maganin. Maganin Tmod™ yana amfani da irin wannan gogewa don lalata ciwace-ciwacen da aka zaɓa yayin da yake keɓance sel na yau da kullun, mai yuwuwar samar da sabuwar hanya mai tsattsauran ra'ayi don amintacciya da ingantaccen maganin cututtukan daji masu ƙarfi.             

"Wadannan takaddun guda biyu suna ba da babban jigon in vitro da in vivo shaida waɗanda ke goyan bayan ƙarfi, zaɓin zaɓi na tsarin Tmod ™, sabon tsarin kula da cutar kansa wanda ke magance kai-kan tsakiyar matsalar cutar sankara - ikon magungunan ciwon daji don bambanta tsakanin ƙari da ƙwayoyin al'ada, "in ji Dokta Alexander Kamb, Babban Jami'in Kimiyya a A2 Bio.

Takardar da aka buga a ranar Maris 2, 2022 a cikin Kimiyyar Fassarar Kimiyya (Sandberg et al., "Maganin kwayar halitta da aka tsara don kai hari ga antigen CEA cikin aminci a cikin zaɓaɓɓun marasa lafiya da ke da ciwace-ciwacen ciwace-ciwacen daji") ya bayyana ɗan takarar na asibiti da aka ba da umarnin ciwace-ciwacen ƙwayar hanji da sauran su. Gabobin da ke ci gaba a halin yanzu zuwa mataki na 1. Dokta Han Xu, Mataimakin Shugaban Fasaha na Therapeutic a A2 Bio kuma babban marubuci a kan takarda, ya ce: "Bayanan mu na asali sun nuna cewa wannan maganin tantanin halitta zai sami karfin aikin asibiti. Ma'auni na warkewa na CEA mai aiki, amma ba tare da guba ba."

Takardar da aka buga a Janairu 28, 2022 a cikin Jarida don ImmunoTherapy na Ciwon daji (Tokatlian et al., "Mesothelin-Specific CAR-T cell far wanda ya haɗa da tsarin tsaro na HLA-gated yana kashe ƙwayoyin tumo") yana nuna yuwuwar aikace-aikacen Tmod Kwayoyin T a cikin ciwon huhu da sauran ciwace-ciwace. Dokta Agi Hamburger, Mataimakin Shugaban Binciken Magungunan Magunguna kuma babban marubuci, yayi sharhi: “Littafinmu ba wai kawai ya bayyana kaddarorin sabon bege ga masu fama da cutar kansar huhu ba amma kuma yana nuna kyakkyawan tsarin dandalinmu na Tmod™, dandalin da muke da shi. fatan za a iya tsawaita don ƙirƙirar hanyoyin kwantar da hankali ga sauran masu fama da cutar kansa a nan gaba. ”

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...